Pediatric Health Market by Type, Therapeutics, Treatment Type - Global Forecast 2025-2030- Product Image

Sale

Pediatric Health Market by Type, Therapeutics, Treatment Type - Global Forecast 2025-2030

Report
189 Pages
October 2024
Region: Global
360iResearch™
ID: 5666270

UP TO €696EUR$697USD£578GBP OFF until Dec 31^st 2024

The Pediatric Health Market grew from USD 106.04 billion in 2023 to USD 113.63 billion in 2024. It is expected to continue growing at a CAGR of 8.00%, reaching USD 181.83 billion by 2030.

The pediatric health market encompasses products, services, and solutions designed to monitor, diagnose, and treat health conditions in children from infancy through adolescence. It is essential due to the distinct physiological and developmental needs of this age group, necessitating specialized medical approaches to ensure optimal growth and well-being. Applications range from preventive care and vaccinations to treatment of chronic and acute illnesses, with end-use involving hospitals, clinics, and home healthcare. Key growth drivers include rising incidences of pediatric disorders, an increasing focus on preventive care, advancements in medical technologies, and expanding healthcare infrastructure in emerging economies. Opportunities abound in areas like telemedicine, which offers increased access to pediatric care, and personalized medicine, with its promise of tailored therapies. To capitalize on these, businesses should invest in technology integration and partnerships with healthcare providers. Nonetheless, market growth faces limitations such as regulatory complexities in drug approvals for pediatric use, high costs of advanced treatment options, and limited healthcare access in underdeveloped regions. Challenges also arise from a shortage of pediatric specialists and the ethical concerns about subjecting children to medical trials. Innovation should focus on non-invasive diagnostic tools, wearable health-monitoring devices, and digital health platforms that engage both young patients and their guardians. Research directed towards developing affordable treatment options and improving patient compliance through educational initiatives can foster growth. The market is dynamic, characterized by rapid technological advancements and evolving healthcare policies. An insightful approach to this market requires continuous monitoring of regulatory landscapes, adaptation to technological trends, and a commitment to addressing unmet medical needs in pediatrics. By strategically addressing these areas, businesses can enhance competitive advantage and ensure sustainable growth in the pediatric health arena.

Understanding Market Dynamics in the Pediatric Health Market

The Pediatric Health Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Significant pediatric population suffering from common childhood Illnesses
- Government initiatives for pediatric immunization programs
- Rising burden of chronic pediatric diseases
Market Restraints
- Limited development of drugs targeting neonates and rare pediatric diseases
Market Opportunities
- Focus on R&D and introduction of novel drugs and new therapeutic developments on rare diseases
- Increasing investment in pediatric drug & vaccine development and its availability
Market Challenges
- Complications associated with drugs

Exploring Porter’s Five Forces for the Pediatric Health Market

Porter’s Five Forces framework further strengthens the insights of the Pediatric Health Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Pediatric Health Market

External macro-environmental factors deeply influence the performance of the Pediatric Health Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Pediatric Health Market

The Pediatric Health Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Pediatric Health Market

The Pediatric Health Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Pediatric Health Market

The Pediatric Health Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Health Market, highlighting leading vendors and their innovative profiles. These include Allucent, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Gilead Sciences, Inc., GlaxoSmithKline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Janssen Global Services LLC, Medexus Pharmaceuticals, Inc., Novartis AG, ORPHELIA Pharma, Pfizer Inc., Procter & Gamble Company, Proveca Ltd., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Pediatric Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Acute Illness
- Chronic Illness
Therapeutics
- Allergy & Immunology
- Cardiology
- Gastroenterology
  - Antacids
  - Antidiarrheal
  - Laxatives
- Infectious Disease
Treatment Type
- Allopathic
  - Drugs
  - Vaccines
- Natural

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant pediatric population suffering from common childhood Illnesses
5.1.1.2. Government initiatives for pediatric immunization programs
5.1.1.3. Rising burden of chronic pediatric diseases
5.1.2. Restraints
5.1.2.1. Limited development of drugs targeting neonates and rare pediatric diseases
5.1.3. Opportunities
5.1.3.1. Focus on R&D and introduction of novel drugs and new therapeutic developments on rare diseases
5.1.3.2. Increasing investment in pediatric drug & vaccine development and its availability
5.1.4. Challenges
5.1.4.1. Complications associated with drugs
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Pediatric Health Market, by Type

6.1. Introduction
6.2. Acute Illness
6.3. Chronic Illness

7. Pediatric Health Market, by Therapeutics

7.1. Introduction
7.2. Allergy & Immunology
7.3. Cardiology
7.4. Gastroenterology
7.4.1. Antacids
7.4.2. Antidiarrheal
7.4.3. Laxatives
7.5. Infectious Disease

8. Pediatric Health Market, by Treatment Type

8.1. Introduction
8.2. Allopathic
8.2.1. Drugs
8.2.2. Vaccines
8.3. Natural

9. Americas Pediatric Health Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Pediatric Health Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Pediatric Health Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. PEDIATRIC HEALTH MARKET RESEARCH PROCESS
FIGURE 2. PEDIATRIC HEALTH MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. PEDIATRIC HEALTH MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PEDIATRIC HEALTH MARKET DYNAMICS
TABLE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ACUTE ILLNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHRONIC ILLNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLERGY & IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ANTIDIARRHEAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 41. CANADA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 43. CANADA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 44. CANADA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 46. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 68. CHINA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 70. CHINA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 71. CHINA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 73. INDIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. INDIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 75. INDIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 76. INDIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 83. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 85. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 86. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 113. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 115. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 116. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 134. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 136. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 137. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 139. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 141. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 142. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 144. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 147. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 149. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 152. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 159. ITALY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 161. ITALY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 162. ITALY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 174. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 177. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 179. POLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. POLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 181. POLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 182. POLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 184. QATAR PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 186. QATAR PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 187. QATAR PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 204. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 219. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 222. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
TABLE 234. PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2023
TABLE 235. PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Pediatric Health Market, which are profiled in this report, include:

Allucent
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Gilead Sciences, Inc.
GlaxoSmithKline PLC
GP Pharm, S.A.
Henin Lukinz Pvt. Ltd.
Janssen Global Services LLC
Medexus Pharmaceuticals, Inc.
Novartis AG
ORPHELIA Pharma
Pfizer Inc.
Procter & Gamble Company
Proveca Ltd.
Sanofi S.A.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 113.63 Billion
Forecasted Market Value ( USD ) by 2030	$ 181.83 Billion
Compound Annual Growth Rate	8.0%
Regions Covered	Global
No. of Companies Mentioned	16

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3542EUR$3,545USD£2,939GBP €3936EUR$3,939USD£3,266GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6267EUR$6,272USD£5,201GBP €6963EUR$6,969USD£5,778GBP

Understanding Market Dynamics in the Pediatric Health Market

Exploring Porter’s Five Forces for the Pediatric Health Market

Applying PESTLE Analysis to the Pediatric Health Market

Analyzing Market Share in the Pediatric Health Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Pediatric Health Market

Strategic Recommendations for Success in the Pediatric Health Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Pediatric Imaging Market by Modality, Application, End-User - Global Forecast 2025-2030

Pediatric Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase III), By Study Design (Treatment Studies, Observational Studies), By Indication, By Region, And Segment Forecasts, 2025 - 2030

Pediatric Dental Market by Type, Disease Type, Procedure - Global Forecast 2025-2030

Pediatric Diabetes Therapeutic Market Size, Share and Trends Analysis Report by Type (Type 1, Type 2), Treatment (Insulin, GLP-1, Biguanide, SGLT2), Route of Administration, Distribution Channel, and Region 2024-2030

Pediatric Imaging - Global Strategic Business Report